Osaic Holdings’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
4,957
-986
-17% -$55K ﹤0.01% 3899
2025
Q4
$333K Sell
5,943
-7,927
-57% -$411K ﹤0.01% 3701
2025
Q3
$663K Buy
13,870
+9,004
+185% +$403K ﹤0.01% 3187
2025
Q2
$198K Buy
4,866
+146
+3% +$5.87K ﹤0.01% 3954
2025
Q1
$207K Buy
4,720
+78
+2% +$3.44K ﹤0.01% 3599
2024
Q4
$200K Sell
4,642
-2,572
-36% -$117K ﹤0.01% 3597
2024
Q3
$320K Sell
7,214
-245
-3% -$10.5K ﹤0.01% 3259
2024
Q2
$297K Buy
7,459
+488
+7% +$19.8K ﹤0.01% 3231
2024
Q1
$301K Buy
6,971
+675
+11% +$29.1K ﹤0.01% 3340
2023
Q4
$262K Buy
6,296
+118
+2% +$4.47K ﹤0.01% 3700
2023
Q3
$246K Buy
6,178
+399
+7% +$16.9K ﹤0.01% 3849
2023
Q2
$237K Sell
5,779
-1,125
-16% -$46.5K ﹤0.01% 3754
2023
Q1
$284K Buy
6,904
+257
+4% +$10.8K ﹤0.01% 3595
2022
Q4
$272K Buy
6,647
+2,910
+78% +$121K ﹤0.01% 3588
2022
Q3
$150K Sell
3,737
-18,511
-83% -$792K ﹤0.01% 4020
2022
Q2
$935K Buy
22,248
+17,340
+353% +$727K ﹤0.01% 2343
2022
Q1
$222K Sell
4,908
-136
-3% -$5.98K ﹤0.01% 3946
2021
Q4
$233K Sell
5,044
-842
-14% -$39.9K ﹤0.01% 3810
2021
Q3
$280K Buy
5,886
+1,667
+40% +$82.8K ﹤0.01% 3608
2021
Q2
$218K Sell
4,219
-9,488
-69% -$476K ﹤0.01% 3799
2021
Q1
$691K Buy
13,707
+1,987
+17% +$106K ﹤0.01% 2551
2020
Q4
$610K Buy
11,720
+6,420
+121% +$307K ﹤0.01% 2462
2020
Q3
$230K Buy
5,300
+2,000
+61% +$87.6K ﹤0.01% 3107
2020
Q2
$141K Sell
3,300
-710
-18% -$29.3K ﹤0.01% 3426
2020
Q1
$145K Buy
+4,010
New +$171K ﹤0.01% 3159

Other funds holding XPH